Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

BACKGROUND: Secondary cytoreductive surgery (SCS) is possible in selected patients with recurrent epithelial ovarian cancer (EOC). The goal of SCS is complete resection, although chemotherapy is always followed. Delayed intervals between primary debulking surgery and adjuvant chemotherapy was report...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Soo Young, Choi, Chel Hun, Kim, Tae Joong, Lee, Jeong Won, Kim, Byoung-Gie, Bae, Duk Soo, Lee, Yoo-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937657/
https://www.ncbi.nlm.nih.gov/pubmed/31892329
http://dx.doi.org/10.1186/s13048-019-0602-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937657/
https://www.ncbi.nlm.nih.gov/pubmed/31892329
http://dx.doi.org/10.1186/s13048-019-0602-5

Ejemplares similares